|
PPFIBP1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.77422529393334E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.06230024776721E-10 |
| Normal-vs-Stage2 |
8.995300E-03 |
| Normal-vs-Stage3 |
1.799720E-02 |
| Normal-vs-Stage4 |
6.963000E-01 |
| Stage1-vs-Stage2 |
7.685200E-01 |
| Stage1-vs-Stage3 |
4.841600E-01 |
| Stage1-vs-Stage4 |
2.221300E-04 |
| Stage2-vs-Stage3 |
8.091000E-01 |
| Stage2-vs-Stage4 |
2.407700E-02 |
| Stage3-vs-Stage4 |
4.614100E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.74659961441159E-10 |
| Normal-vs-AfricanAmerican |
1.61070000004315E-07 |
| Normal-vs-Asian |
2.447000E-01 |
| Caucasian-vs-AfricanAmerican |
2.924200E-01 |
| Caucasian-vs-Asian |
8.776000E-01 |
| AfricanAmerican-vs-Asian |
6.108600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.25739476795206E-12 |
| Normal-vs-Female |
1.81843000000015E-05 |
| Male-vs-Female |
9.952000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
9.183500E-03 |
| Normal-vs-Extreme_Weight |
2.13540000004731E-06 |
| Normal-vs-Obese |
6.74080000040433E-07 |
| Normal-vs-Extreme_Obese |
3.138400E-02 |
| Normal_Weight-vs-Extreme_Weight |
2.594000E-01 |
| Normal_Weight-vs-Obese |
7.980200E-02 |
| Normal_Weight-vs-Extreme_Obese |
3.236000E-01 |
| Extreme_Weight-vs-Obese |
4.192200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
7.333800E-01 |
| Obese-vs-Extreme_Obese |
9.375600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.820800E-03 |
| Normal-vs-Age(41-60Yrs) |
2.00000016548074E-11 |
| Normal-vs-Age(61-80Yrs) |
3.66319999889342E-08 |
| Normal-vs-Age(81-100Yrs) |
2.064200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.620600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.915800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.228630E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.344100E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.299300E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.993600E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.62458935193399E-12 |
| Normal-VS-Type2 PRCC |
7.564800E-03 |
| Normal-VS-KIRP CIMP |
6.983400E-01 |
| Normal-VS-Unclassified PRCC |
3.386400E-04 |
| Type1 PRCC-VS-Type2 PRCC |
1.93250000002365E-06 |
| Type1 PRCC-VS-KIRP CIMP |
1.78277999999255E-05 |
| Type1 PRCC-VS-Unclassified PRCC |
8.948000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.555970E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.747970E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
6.849100E-04 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.261100E-03 |
| Normal-vs-N1 |
2.226300E-02 |
| Normal-vs-N2 |
8.909400E-01 |
| N0-vs-N1 |
9.916400E-01 |
| N0-vs-N2 |
3.676000E-01 |
| N1-vs-N2 |
2.967400E-01 |
|
|
